(Q44574645)

4 December 2017

Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients (English)

1 reference

4 December 2017

1 reference

Kwang Kon Koh

1

1 reference

4 December 2017

Jeong Yeal Ahn

2

1 reference

4 December 2017

Seung Hwan Han

3

1 reference

4 December 2017

Dae Sung Kim

4

1 reference

4 December 2017

Dong Kyu Jin

5

1 reference

4 December 2017

Hyung Sik Kim

6

1 reference

4 December 2017

Mi-Seung Shin

7

1 reference

4 December 2017

Tae Hoon Ahn

8

1 reference

4 December 2017

In Suck Choi

9

1 reference

4 December 2017

Eak Kyun Shin

10

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Journal of the American College of Cardiology

4 December 2017

1 reference

4 December 2017

42

1 reference

4 December 2017

5

1 reference

4 December 2017

905-910

1 reference

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Prognostic significance of endothelial dysfunction in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Mechanism by which quinapril improves vascular function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Greater oxidative stress in healthy young men compared with premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effects of HMG-CoA reductase inhibitor on hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Inhibition of platelet aggregability by losartan in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900846-5

7 January 2021

10.1016/S0735-1097(03)00846-5

Identifiers

DOI

1 reference

release_xw5b7eqlwfdcleigywnr4dqjp4

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xw5b7eqlwfdcleigywnr4dqjp4

24 November 2022

mapped directly with Wikidata item

1 reference